FDA approves adjunctive therapy to treat partial-onset seizures

摘要

The FDA approved brivaracetam (Briviact) as adjunctive treatment to other medications to treat partial-onset seizures in patients age 16 and older with epilepsy. Brivaracetam's effectiveness was studied in three clinical trials involving 1,550 participants. Brivaracetam, taken along with other medications, was shown to be effective in reducing the frequency of seizures.